IOL Chemicals & Pharmaceuticals Q3 FY26 Results: Revenue ₹5.8 Bn, Profit ₹205.8 Mn, Interim Dividend Declared

IOL Chemicals and Pharmaceuticals Limited, a leading manufacturer in the chemicals and active pharmaceutical ingredients (API) segment, announced its December quarter (Q3 FY26) results. The company posted consolidated revenue from operations of ₹5.8 billion and net profit of ₹205.8 million, underscoring resilience in a competitive market environment.

Alongside its earnings, the board declared an interim dividend of ₹1 per share, reinforcing its focus on shareholder value creation. The company continues to strengthen its position in both domestic and global markets, driven by operational efficiency and innovation in the pharma-chemicals space.

Key Highlights

• Revenue Performance: Consolidated revenue from operations stood at ₹5.8 billion in Q3 FY26.
• Profitability: Net profit after tax reported at ₹205.8 million.
• Dividend Declaration: Interim dividend of ₹1 per share announced.
• Sectoral Strength: Continued focus on chemicals and APIs with emphasis on efficiency and innovation.
• Market Outlook: Strong positioning in domestic and international markets with sustainable growth strategies.

This performance highlights IOL Chemicals’ ability to balance profitability with strategic investments, ensuring long-term growth and shareholder confidence.

Sources: CNBC-TV18, Mint, FilingReader Intelligence